- dsm-firmenich completes the divestiture of its Jiangshan Vitamin C plant in China
- dsm-firmenich publishes 2023 Integrated Annual Report
- dsm-firmenich to separate out Animal Nutrition & Health business from the Group
- dsm-firmenich reports full year 2023 results
- dsm-firmenich completes voluntary cash offer for DSM shares
- dsm-firmenich makes voluntary cash offer for DSM shares
More ▼
Key statistics
As of last trade DSM-Firmenich AG (DSFIR:AEX) traded at 105.74, -13.37% below its 52-week high of 122.06, set on Apr 24, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 106.32 |
---|---|
High | 106.32 |
Low | 104.60 |
Bid | 105.72 |
Offer | 105.74 |
Previous close | 106.10 |
Average volume | 419.38k |
---|---|
Shares outstanding | 265.68m |
Free float | 68.83m |
P/E (TTM) | -- |
Market cap | 28.19bn EUR |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Mar 28 2024 16:06 BST.
More ▼